Structurally Diverse Benzoazepines Clubbed with Coumarins
8. Raviglione M.C., Smith I.M. (2007) XDR Tuberculosis-implications
2-one derivatives as antitubercular agents. Indian Pat Appl
IN 2010DE01244 A 20120302.
for global public health. N Engl J Med;356:656–659.
9. Moraski G.C., Markley L.D., Hipskind P.A., Boshoff H., Cho S.,
Franzblau S.G., Miller M.J. (2011) Advent of imidazo[1,2-a]pyri-
dine-3-carboxamides with potent multi- and extended drug resis-
tant antituberculosis activity. ACS Med Chem Lett;2:466–470.
10. Dover L.G., Coxon G.D. (2011) Current status and research strate-
gies in tuberculosis drug development. J Med Chem;54:6157–
6165.
11. Yew W.W., Lange C., Leung C.C. (2011) Treatment of tuberculo-
sis: update 2010. Eur Respir J;37:441–462.
12. Nayyar A., Jain R. (2005) Recent advances in new structural
classes of anti-tuberculosis agents. Curr Med Chem;12:1873–
1886.
13. Da Silva P.E.A., Palomino J.C. (2011) Molecular basis and mecha-
nisms of drug resistance in Mycobacterium tuberculosis: classi-
cal and new drugs. J Antimicrob Chemother;66:1417–1430.
14. Yew W.W., Cynamon M., Zhang Y. (2011) Emerging drugs for the
treatment of tuberculosis. Expert Opin Emerging Drugs;16:1–21.
15. Upadhyay K., Bavishi A., Thakrar S., Radadiya A., Vala H., Parekh
S., Bhavsar D., Savant M., Parmar M., Adlakha P., Shah A.
(2011) Synthesis and biological evaluation of 4-styrylcoumarin
derivatives as inhibitors of TNF-a and IL-6 with anti-tubercular
activity. Bioorg Med Chem Lett;21:2547–2549.
24. Currens M.J., Gulakowski R.J., Mariner J.M., Moran R.A., Buck-
heit R.W., Gustafson K.R., McMahon J.B., Boyd M.R. (1996)
Antiviral activity and mechanism of action of calanolide A
against the human immunodeficiency virus type-1. J Pharmacol
Exp Ther;279:645–651.
25. Manvar A., Bavishi A., Radadiya A., Patel J., Vora V., Dodia N.,
Rawal K., Shah A. (2011) Diversity oriented design of various
hydrazides and their in vitro evaluation against Mycobacterium
tuberculosis H37Rv strains. Bioorg Med Chem Lett;21:4728–
4731.
26. Dandia A., Sati M., Arya K., Sharma R., Loupyb A. (2003) Facile
one pot microwave induced solvent-free synthesis and antifun-
gal, antitubercular screening of spiro[1,5]-benzothiazepin-
2,3¢[3¢H]indol-2[1¢H]-ones. Chem Pharm Bull;51:1137–1141.
27. Dandia A., Upreti M., Rani B., Pant U.C., Gupta I.J. (1998) Syn-
thesis and antimicrobial evaluation of some new fluorinated
spiro[[1,5]-benzothiazepin-2,3¢[3¢H]-indol]-2¢(1¢H)-ones. J Fluorine
Chem;91:171–174.
28. Kamal A., Reddy K.L., Devaiah V., Shankaraiah N., Reddy G.S.K.,
Raghvan S. (2007) Solid-phase synthesis of a library of pyrrol-
o[2,1-c][1,4]benzodiazepine-5,11-diones with potential antituber-
cular activity. J Comb Chem;9:29–42.
16. Virsodia V., Shaikh M.S., Manvar A., Desai B., Parecha A., Loriya
R., Dholariya K., Patel G., Vora V., Upadhyay K., Denish K., Shah
A., Coutinho E.C. (2010) Screening for in vitro antimycobacterial
activity and three-dimensional quantitative structure-activity rela-
tionship (3D-QSAR) study of 4-(arylamino)coumarin derivatives.
Chem Biol Drug Des;76:412–424.
17. Manvar A., Malde A., Verma J., Virsodia V., Mishra A., Upadhyay
K., Acharya H., Coutinho E.C., Shah A. (2008) Synthesis, anti-
tubercular activity and 3D-QSAR study of coumarin-4-acetic acid
benzylidene hydrazides. Eur J Med Chem;43:2395–2403.
18. Manvar A., Pissurlenkar R.R.S., Virsodia V., Upadhyay K., Manvar
D., Mishra A., Acharya H., Parecha A., Dholakia C., Shah A., Cout-
inho E.C. (2011) Synthesis, in vitro antitubercular activity and 3D-
QSAR study of 1,4-dihydropyridines. Mol Divers;14:285–305.
19. Kharkar P.S., Desai B., Gaveria H., Varu B., Loriya R., Naliapara
Y., Shah A., Kulkarni V.M. (2002) Three-dimensional quantitative
structure-activity relationship of 1,4-dihydropyridines as antitu-
bercular agents. J Med Chem;45:4858–4867.
29. Kabir M.S., Namjoshi O.A., Verma R., Polanowski R., Krueger
S.M., Sherman D., Rott M.A., Schwan W.R., Monte A., Cook
J.M. (2010) A new class of potential anti-tuberculosis agents:
synthesis and preliminary evaluation of novel acrylic acid ethyl
ester derivatives. Bioorg Med Chem;18:4178–4186.
30. Omelchenko A., Bouchard R., Le H.D., Choptiany P., Visen N.,
Hnatowich M., Hryshko L.V. (2003) Inhibition of canine (NCX1.1)
and Drosophila (CALX1.1) Na+-Ca2+exchangers by 7-chloro-3,5-di-
hydro-5-phenyl-1H-4,1-benzothiazepine-2-one (CGP-37157).
J
Pharmacol Exp Ther;306:1050–1057.
31. Campiani G., Fiorini I., De Filippis M.P., Ciani S.M., Garofalo A.,
Nacci V., Giorgi G., Sega A., Botta M., Chiarini A., Budriesi R.,
Bruni G., Romeo M.R., Manzoni C., Mennini T. (1996) Cardiovas-
cular characterization of pyrrolo[2,1-d][1,5]benzothiazepines deriv-
atives binding selectively to the peripheral-type benzodiazepine
receptor (PBR): from dual PBR affinity and calcium antagonist
activity to novel and selective calcium entry blockers. J Med
Chem;39:2933–2938.
20. Dodia N., Shah A. (2000) Synthesis and antitubercular activity of
some substituted 3-nitro and 3-bromo-4-hydroxy-2-quinolones.
Indian J Heterocy Ch;10:69–70.
21. Virsodia V., Pissurlenkar R.R.S., Manvar D., Dholakia C., Adlakha
P., Shah A., Coutinho E.C. (2008) Synthesis, screening for antitu-
bercular activity and 3D-QSAR studies of substituted N-phenyl-6-
methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydro-pyrimidine-5-carboxa-
mides. Eur J Med Chem;43:2103–2115.
22. Sarkar D., Sarkar S., Joshi R.R., Khedkar V.M., Pissurlenkar R.R.,
Coutinho E.C., Shah A.K. (2011) 1,6-Methyl-4-phenyl-5-(phenyl or
cycloalkyl) carbamoyl-1,2,3,4-tetrahydropyrimidin-2-one deriva-
tives as antitubercular agents. PCT Int Appl, WO 2011 ⁄ 151701
A1 20111208.
23. Sarkar D., Sarkar S., Joshi R.R., Khedkar V.M., Pissurlenkar R.R.,
Coutinho E.C., Shah A.K. (2012) Preparation of 6-methyl-4-phe-
nyl-5-(phenyl or cyclohexyl)carbamoyl-1,2,3,4-tetrahydropyrimidin-
32. Bolli M.H., Marfurt J., Grisostomi C., Boss C., Binkert C., Hess
P., Treiber A., Thorin E., Morrison K., Buchmann S., Bur D.,
Ramuz H., Clozel M., Fischli W., Weller T. (2004) Novel
benzo[1,4]diazepin-2-one derivatives as endothelin receptor
antagonists. J Med Chem;47:2776–2795.
33. Bariwal J.B., Upadhyay K.D., Manvar A.T., Trivedi J.C., Singh
J.S., Jain K.S., Shah A.K. (2008) 1,5-Benzothiazepine, a versatile
pharmacophore: a review. Eur J Med Chem;43:2279–2290.
34. Mogilaih K., Sudhakar G.R. (2003) Synthesis of pyrazoline, pyrim-
idine and 1,5-benzodiazepine derivatives of 1,8-naphthyridine
and evaluation of antibacterial activity. Indian J Chem;42B:636–
640.
35. Kumar P.V., Rao V.R. (2008) Synthesis of pyrazoline, pyrimidine
and 1,5-benzodiazepine derivatives of 1,8-naphthyridine and
evaluation of antibacterial activity. Indian J Chem;47B:106–
111.
Chem Biol Drug Des 2012; 80: 1003–1008
1007